SSRI Preemption Case Settles While on Appeal to 10th Circuit

OKLAHOMA CITY – An Effexor suicide case brought against Wyeth Pharmaceuticals has settled while on appeal to the 10th Circuit U.S. Court of Appeals, according to the parties’ counsel.

The plaintiff was appealing a June 2011 ruling in which the U.S. District Court for the Western District of Oklahoma found her failure-to-warn claims are federally preempted because the Food and Drug Administration would have rejected Wyeth’s efforts to unilaterally strengthen Effexor’s warning label.

Annabel Dobbs sued Wyeth in the U.S. District Court for the Western District of Oklahoma on behalf of her husband, Terry, who committed suicide in 2002 days …